Anish Patel

Chief Operating Officer, Enliven Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$1.6M

Companies

Latest trade

Jan 9, 2026

Companies

Enliven Therapeutics, Inc.Chief Operating Officer −$1.7M

Trades

ELVN Sold 48,300 shares at $27.98 · planned $1.4M Jan 9

ELVN Sold 6,663 shares at $21.02 · planned $0.1M Dec 8

ELVN Sold 6,667 shares at $17.40 · planned $0.1M Nov 7

ELVN Sold 6,667 shares at $20.10 · planned $0.1M Oct 7

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.